Leukotriene (LT)B4 promotes leukocyte chemotaxis and adhesion to the endothelium of postcapillary venules. The cysteinyl leukotrienes, LTC4, LTD4, and LTE4, elicit macromolecular leakage from this vessel segment. Both leukocyte adhesion to the endothelium and macromolecular leakage from postcapillary venules hallmark the microcirculatory failure after ischemia-reperfusion, suggesting a role of leukotrienes as mediators of ischemia-reperfusion ijury.
Introduction
Reperfusion injury after focal ischemia to organs and skeletal muscle has been implicated in the development ofmulti-organ failure and death after primarily successful resuscitation from multiple injury and shock (1) . Chemotactic accumulation, activation, and adherence of circulating leukocytes to the endothelium ofpostcapillary venules hallmark the microcirculatory manifestations ofischemia-reperfusion injury (2-7). Enhanced leukocyte aggregation and altered viscoelastic properties of activated leukocytes favor microvascular obstruction (3, 5) . Toxic oxygen radicals and degranulation products like hydro-lytic enzymes contribute to the full manifestation of ischemiareperfusion injury (8) (9) (10) (11) , characterized by the breakdown of capillary perfusion and the loss of endothelial integrity (2, 5, 12) .
Leukotrienes, metabolites of arachidonate produced in the 5-lipoxygenase pathway, initiate many of the symptoms associated with ischemia-reperfusion injury. The cysteinyl leukotrienes (LT),' LTC4, LTD4, and LTE4, affect the tonus of the arterioles and the permeability of postcapillary venules, thereby causing endothelial contraction and macromolecular leakage (13) (14) (15) (16) . The dihydroxylated LTB4, one of the most powerful chemotactic substances known, has been implicated in the process of leukocyte accumulation, adhesion to the microvascular endothelium, emigration from the blood stream at sites of inflammation (13, (17) (18) (19) , degranulation, and release of lysosomal enzymes (20) (21) (22) as well as generation of oxygen radicals (22, 23).
There is evidence that leukotrienes, in particular LTB4, enhance leukocyte adhesion to the endothelium by a mechanism dependent on the expression of the CDl 1/CD 1 8 (Mac-l) glycoprotein family (24) on the leukocyte surface (25, 26) . Monoclonal antibodies, which bind to the CD18 glycoprotein portion of the leukocyte adhesion receptors, were reported to inhibit LTB4-induced chemotaxis, adhesion of leukocytes to the endothelium, and macromolecular leakage (11, (26) (27) (28) and thus alleviate ischemia-reperfusion injury (29, 30) .
The concept that leukotrienes are involved in ischemia-reperfusion injury has furthermore been supported by reports of enhanced generation of 5-lipoxygenase products in postischemic organs (31) (32) (33) (34) . The recent demonstration of enhanced leukotriene levels in venous effluent from hindlimbs after experimental ischemia and reperfusion (35) suggests that similar mechanisms exist in striated skeletal muscle.
It was the aim of this study to investigate the mediator role of leukotrienes in the pathogenesis of ischemia-reperfusion injury in striated muscle. Using the dorsal skinfold chamber model in hamsters (36) for intravital microscopy ofthe microcirculation of striated muscle, we demonstrate in this report that leukotrienes elicit the same pattern of microcirculatory changes as ischemia-reperfusion injury and that the postischemic microcirculatory failure can be effectively prevented by the inhibition of leukotriene generation or leukotriene receptors, suggesting the key role of leukotrienes in ischemia-reperfusion injury in the striated muscle in vivo.
Methods
Animal model. For intravital fluorescence microscopy, we used the dorsal skinfold chamber preparation in awake Syrian golden hamsters (36). This model permits the microscopic quantification of leukocyte/ endothelium interaction, macromolecular leakage, and the microhemodynamic parameters vessel diameter and red cell velocity in postcapillary venules ofa thin striated muscle contained within the observation window.
Operative technique. The experimental preparation used in this study is similar, except for minor modifications, to that described previously in detail (36). Briefly, Syrian golden hamsters (6-8 wk old, weighing 60-80 g) were anesthetized by intraperitoneal injection of pentobarbital (60 mg/kg body weight; Nembutal, Abbott, Wiesbaden, Germany). The entire back of the animals was shaven and two titanium frames were implanted so as to sandwich the extended double layer of the skin. One layer was completely removed in a circular area of 15 mm in diameter and the remaining layer, consisting ofepidermis, subcutaneous tissue, and a thin striated skin muscle was covered with a cover slip incorporated in one of the frames. Fine polyethylene catheters ([PE] 10, inner diameter 0.28 mm) were inserted into the jugular vein and the carotic artery, respectively, passed subcutaneously to the dorsal side of the neck, and sutured to the titanium frames. The animals tolerated the dorsal skinfold chambers well and showed no signs of discomfort. In particular, no effect on sleeping and feeding habits were observed.
Intravital fluorescence microscopy. A recovery period of 48-72 h between implantation ofthe observation chamber and the microscopic investigation was allowed to eliminate the effects of anesthesia and surgical trauma on the microvasculature. A 4-h ischemia was induced to the chamber tissue by gently pressing the muscle against the cover, slip with a silicone pad and an adjustable screw, just sufficient to empty the blood vessels (6) . A 25-fold water immersion objective (total magnification 560-fold; E. Leitz, Inc., Wetzlar, Germany) was used to select four to six sites of interest per chamber, each containing one or several postcapillary venules or collecting venules (10-60 Mm in diameter). These vessel segments were chosen for investigation, because they are considered the major site of interaction between leukocytes and the endothelium in response to noxious stimuli (37) . By means of a computer-controlled stepping motor (38) the identical vessel segments were investigated for leukocyte/endothelium interaction, diameter, and red cell velocity before ischemia and at all times after reperfusion. For visualization of leukocytes, the in vivo fluorescent marker acridine orange (Sigma Chemical Co., St. Louis, MO) was infused intravenously at a constant rate of 0.5 mg kg-' min' for a maximum microscopic recording of4-6 min. Epiillumination was achieved with a 75 W, DC, xenon lamp attached to a Ploemopak illuminator (E. Leitz, Inc.) with a 12 blue filter block. The microscopic images (Camera COHU 4400; Prospective Measurements, San Diego, CA) were recorded on video tape and analyzed during playback using the computer-assisted Microcirculation Analysis System (CAMAS) (38) . Adhesive leukocytes were defined as cells that did not move or detach from the endothelial lining within the observation time of 1 min and are given as number of cells per mm2 ofendothelial surface as calculated from diameter and length of the vessel segment studied (200 Mm). Macromolecular leakage was assessed by intravenous injection of FITC-conjugated dextran (Mr 150,000, 5 mg in 100 Ail saline; Pharmacia Fine Chemicals, Uppsala, Sweden), intravital microscopy (total magnification 40-fold), and planimetric quantification of the area where the fluorescent marker had extravasated into the interstitial space, given as a percentage of the observation field (38) .
Topical leukotriene application. In order to assess the direct microcirculatory effects of topical leukotriene administration, the leukotrienes LTB4, LTD4, (Amersham Buchler, Braunschweig, Germany), and the vehicle (1% ethanol in 0.9% saline) were superfused fora period of 3 min directly onto the striated muscle within the observation window at a concentration of 20 and 5 nM, respectively. The superfusates were then washed away with physiological saline and leukocyte/endothelium interaction, vessel diameters, and red cell velocities were assessed in the follow-up period of 20 min by intravital fluorescence microscopy.
Inhibition ofleukotriene synthesis and action. The selective inhibi- precolumn (Waters Associates, Milford, MA). The mobile phase consisted of 38% (vol/vol) acetonitrile in aqueous buffer (0.1% acetic acid, pH 5.7, adjusted with ammonium hydroxide). The flow rate was 1 ml per min. A 400-,g aliquot of each l-ml fraction collected during HPLC was counted for calculation of tritium recovery, and 600 Mul were dried for the subsequent RIA. The amount of immunoreactive leukotriene metabolites coeluting with the [3H]leukotriene standards added to each sample before HPLC were corrected for recovery losses and immunological cross-reactivity in the RIA. The LTB4 RIA was performed according to the procedure provided by Amersham Buchler. Instead of the charcoal separation system a scintillation proximity assay (protein A) was used. The molar crossreactivities of the LTB4 antibody at 50% binding were: LTB4, 100%; 20-OH-LTB4, 0.4%; 6-trans-LTB4, 0.4%; other eicosanoids, < 0.05%. The RIA for cysteinyl leukotrienes was performed as previously described (43 
Results
Microcirculatory changes after ischemia and reperfusion.
While under normal conditions, represented by the preischemic baseline situation, the majority ofleukocytes passing postcapillary venules and collecting venules did not interact with the endothelial surface, ischemia-reperfusion elicited leukocyte adhesion to the microvascular endothelium with a maximum 0.5 h after reperfusion (Figs. 1 and 2 A) . This phenomenon was seen in all venules ranging from diameters of 10 to 60 ,m. Postischemic leukocyte/endothelium interaction then gradually declined until 24 h after reperfusion (Fig. 2 A) . Likewise, macromolecular leakage from postcapillary venules was observed at 0.5 and 2 h after reperfusion (Fig. 3 A) . No 24-h values could be obtained for macromolecular leakage because of the highly fluorescent background from preceding investigations.
Postischemic leukotriene accumulation. We analyzed the content of 5-lipoxygenase products in the postischemic striated muscle within the observation window after deep-freezing by sequential RP-HPLC and RIA (41) (42) (43) . The contents of LTB4 and cysteinyl leukotrienes were significantly increased in postischemic tissues 0.5 h after reperfusion as compared with nonischemic control tissue (Table I) .
Topical leukotriene application. To test whether topical leukotriene application provoked similar changes in the microcirculation as ischemia-reperfusion, LTB4 and LTD4 were superfused directly onto the striated muscle within the observation window. LTB4 superfusion resulted in an immediate induction of leukocyte adhesion to the endothelium ofpostcapillary venules and collecting venules, with a maximum at 10 min after superfusion (Fig. 2 B) . LTD4 superfusion caused pronounced macromolecular leakage from these microvascular segments (Fig. 3 B) , the time course of this effect being similar as the induction ofleukocyte adhesion after LTB4 challenge. Changes ofred blood cell velocity and vessel diameter were not observed after leukotriene application. Superfusion with the vehicle had no effect on leukocyte/endothelium interaction, macromolecular leakage, or microhemodynamic parameters, suggesting that neither the vehicle nor the experimental condition imposed any artefacts on these assessments.
Inhibition ofleukotriene biosynthesis. In order to demonstrate the essential role of leukotrienes in ischemia-reperfusion injury ofstriated muscle, leukotriene biosynthesis was pharmacologically inhibited by MK-886, which selectively blocks 5-lipoxygenase activation in vitro (39) and in vivo (39, 43) . Effective plasma levels ofMK-886 were ascertained at various times by the measurement of LTB4 generation in whole blood after ex vivo stimulation with the calcium ionophore A23187 according to Tateson et al. (44) . The applied dose ofMK-886 did not induce changes in blood pressure and heart rate. After 4 h of ischemia and 0.5 h of reperfusion, the accumulation of LTB4, LTD4, LTC4, and LTE4 in the postischemic chamber tissue was almost completely suppressed in MK-886-treated animals (Table I) (41) (42) (43) . Values are given in pmol/g wet weight. Measurements were performed on animals treated with MK-886 (n = 7) or vehicle (n = 7). 2LTcys designates total cysteinyl leukotrienes. Data are the mean±SEM. * P < 0.001 as compared with nonischemic tissue, and * P < 0.01 as compared with postischemic tissue in vehicle-treated animals.
capillary venules were significantly reduced in MK-886-treated animals ( Fig. 2 A and 3 A) . Differences in postischemic red cell velocities and vessel diameters were not observed between MK-886-treated and control animals (Table II) , nor were there differences in systemic blood pressure. Although we cannot rule out changes in perfusion pressure within the observed microvessel segments, these data suggest that the effects of MK-886 on the microcirculatory manifestations of ischemia-reperfusion injury were not secondary to microhemodynamic changes or changes in local wall shear force conditions. Leukotriene receptor antagonist. To further differentiate the effects of LTB4 and of cysteinyl leukotrienes, we administered the selective LTD4/E4 receptor antagonist MK-57 1. Postischemic macromolecular leakage from postcapillary venules was entirely prevented by pretreatment with MK-571 (Fig. 3  A) . Under this condition, no reduction was observed of postischemic leukocyte adhesion 30 min after reperfusion in these Red cell velocity and vessel diameters were assessed in four to six postcapillary venules per observation chamber before ischemia and in identical vessel segments at defined times after reperfusion. Red cell velocity was assessed by cross-correlation and vessel diameters were assessed planimetrically (38) . Data are the mean±SD of n = 7 animals in the vehicle-treated control group and n = 7 animals in the MK-886-treated group.
vessel segments (639±287 cells/mm2 vs. 761±344 cells/mm2 in control animals).
Discussion
Leukocyte/endothelium interaction and macromolecular leakage from postcapillary venules are characteristic features of ischemia-reperfusion injury. The demonstration that these events can be mimicked by topical application of leukotrienes ( Fig. 2 B and 3 B ) is in accordance with earlier in vitro and in vivo findings in which LTB4 was shown to exert powerful chemotactic activities and promote leukocyte adhesion to and emigration across the endothelial wall ofpostcapillary venules (13, 17, 19) , whereas the cysteinyl leukotrienes LTC4, LTD4, and LTE4 were implicated in the regulation of vessel permeability and the induction of macromolecular leakage (13, 14) .
The concept that leukotrienes are involved in ischemia-reperfusion injury is furthermore supported by the demonstration that leukotrienes accumulate in the postischemic striated muscle 0.5 h after reperfusion (Table I ). This finding is in consistence with, and extends, previous reports on increased leukotriene generation in postischemic brain (31) , intestine (34) , and myocardium (32) , as well as elevated leukotriene levels in venous effluent after temporal renal (33) and hindlimb ischemia (35) .
When endogenous leukotriene biosynthesis was pharmacologically inhibited by pretreating the animals with the leukotriene biosynthesis inhibitor MK-886, both postischemic leukotriene accumulation and the microcirculatory changes of ischemia-reperfusion injury were entirely prevented (Figs. 2 A and 3 A). This finding extends previous observations obtained in the same animal model, where postischemic capillary blockade was effectively prevented by pretreatment of the animals with the same leukotriene biosynthesis inhibitor (45) , and supports the idea that enhanced leukocyte adhesivity accounts for capillary obstruction after ischemia-reperfusion (7) .
The concept that LTB4 accounts for postischemic leukocyte/endothelium interaction, while the cysteinyl leukotrienes mediate macromolecular leakage, is furthermore substantiated by the finding that postischemic macromolecular leakage was effectively prevented by pretreating the animals with the LTDSE4 receptor antagonist MK-57 1 (Fig. 3 A) . These results emphasize the pivotal role ofcysteinyl leukotrienes in the regulation of postischemic vessel permeability (13, 14) .
MK-886 inhibits leukotriene biosynthesis by blocking the Ca++-dependent translocation ofcytosolic 5-lipoxygenase to its membrane-bound activator protein (46) (47) (48) . In contrast to previously available lipoxygenase inhibitors, which inhibit various lipoxygenases via redox mechanisms (3, (32) (33) (34) 49) , MK-886 specifically inhibits the synthesis of 5-lipoxygenase products and exerts no nonspecific antioxidant effects (39) . This fact is ofparticular relevance because oxygen radicals contribute to ischemia-reperfusion injury (8, 10, I 1) and since radical scavengers have been reported to alleviate ischemia-induced leukocyte accumulation (3, 9-1 1) and macromolecular leakage (2, 50) . Using nonspecific lipoxygenase inhibitors and antioxidants, it could not be decided whether the lipoxygenase inhibitors interfered with oxygen radical formation or, in turn, whether antioxidants interfered with leukotriene generation. Therefore, it was not possible to differentiate the effects of leukotrienes from the effects ofoxygen radicals on the microcircu-latory manifestation of ischemia-reperfusion injury (3, (32) (33) (34) 49) . This problem has recently been addressed in an in vitro study where nonoxidant lipoxygenase inhibitors were demonstrated to be devoid of direct inhibitory effects on leukocytes, supporting the concept that the salvaging effect ofthese inhibitors in ischemia-reperfusion is due to the inhibition of leukotriene generation (51) . Our use ofa selective inhibitor ofleukotriene biosynthesis, which exerts no nonspecific antioxidant effects (39) , together with leukotriene analysis in the postischemic tissue, has now allowed to demonstrate the key role of leukotrienes in ischemia-reperfusion injury in striated muscle. However, it should be considered that, depending on tissue type, animal species, and experimental setting, leukotrienes will be only part ofa network ofmediators comprising complement factors (52) , other eicosanoids such as thromboxane A2 (see reference 33) and lipid mediators like platelet activating factor (53) .
Inhibition ofeither leukotriene or oxygen radical formation alone prevents postischemic leukocyte adhesion and tissue injury, which suggests that the joint action of both classes of mediators is necessary for the adequate microcirculatory response to ischemia-reperfusion. Because oxygen radical scavengers failed to inhibit leukocyte adhesion to endothelial monolayers in response to chemoattractants like LTB4 and fMPL (54), Granger et al. (10) have put forward the hypothesis that oxygen radicals, produced at the moment of reperfusion through the action ofxanthine oxidase, initialize the formation of further mediators which then activate and promote the adhesion of leukocytes to the microvascular endothelium. The results obtained in this study as well as data from the literature (32) suggest that these adhesion promoting mediators are leukotrienes, in particular LTB4, generated and released from locally activated leukocytes.
Ischemia-reperfusion-induced macromolecular leakage has been found significantly attenuated by the inhibition ofleukocyte/endothelium interaction through leukocyte depletion (5, 55) or monoclonal antibodies directed towards leukocyte adhesion molecules (5). These observations indicate that leukocyte adhesion to the endothelium is a critical step in the sequelae leading to ischemia-reperfusion injury and suggest that macromolecular leakage is promoted by substances released from leukocytes after adhesion and degranulation (10) . Our observation that pretreatment with the highly selective LTD4/E4 receptor antagonist MK-57 1 (Fig. 3 A; reference 40) effectively inhibited macromolecular leakage without affecting leukocyte/endothelium interaction suggests that cysteinyl leukotrienes, generated by adherent leukocytes, are substantially involved in the loss of endothelial integrity.
Taken together, our results suggest that in addition to the role of oxygen free radicals, leukotrienes play a key role in ischemia-reperfusion injury in vivo by mediating both the recruitment and adhesion ofleukocytes to the microvascular endothelium and the loss of endothelial integrity.
